DexCom, Inc. (DXCM) Reports Q3 Loss of 20c, Misses by 4c
DexCom, Inc. (NASDAQ: DXCM) reported Q3 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $19.05 million.